[go: up one dir, main page]

DK272889A - Vaccine - Google Patents

Vaccine Download PDF

Info

Publication number
DK272889A
DK272889A DK272889A DK272889A DK272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A DK 272889 A DK272889 A DK 272889A
Authority
DK
Denmark
Prior art keywords
vaccine
Prior art date
Application number
DK272889A
Other languages
Danish (da)
English (en)
Other versions
DK272889D0 (da
Inventor
Werner Altenburger
Mary-Helen Binger
Richard Anthony Chizzonite
Richard Allen Kramer
Peter Thomas Lomedico
Stephen J Mcandrew
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK272889D0 publication Critical patent/DK272889D0/da
Publication of DK272889A publication Critical patent/DK272889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK272889A 1988-06-03 1989-06-02 Vaccine DK272889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20272188A 1988-06-03 1988-06-03

Publications (2)

Publication Number Publication Date
DK272889D0 DK272889D0 (da) 1989-06-02
DK272889A true DK272889A (da) 1989-12-04

Family

ID=22750986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272889A DK272889A (da) 1988-06-03 1989-06-02 Vaccine

Country Status (22)

Country Link
US (2) US5661015A (fr)
EP (1) EP0344808B1 (fr)
JP (1) JP3051130B2 (fr)
KR (1) KR0156545B1 (fr)
CN (3) CN1040126C (fr)
AR (1) AR241942A1 (fr)
AT (1) ATE120489T1 (fr)
AU (1) AU635704B2 (fr)
CA (1) CA1340538C (fr)
DE (1) DE68921923T2 (fr)
DK (1) DK272889A (fr)
ES (1) ES2070866T3 (fr)
FI (1) FI101453B (fr)
HU (1) HU212505B (fr)
IE (1) IE67544B1 (fr)
IL (1) IL90489A0 (fr)
MC (1) MC2039A1 (fr)
NO (1) NO303876B1 (fr)
NZ (1) NZ229377A (fr)
PT (1) PT90727B (fr)
YU (1) YU47880B (fr)
ZA (1) ZA893740B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5824656A (en) * 1988-01-15 1998-10-20 Merck & Co., Inc. Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
EP0432168B1 (fr) * 1988-07-05 1996-10-16 British Technology Group Usa Inc Vaccin contre la coccidiose prepare par genie genetique
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
EP0403698B1 (fr) * 1989-06-21 1993-09-08 Akzo Nobel N.V. Vaccin contre Eimeria tenella
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
DK0575317T3 (da) * 1991-03-14 1996-12-09 British Tech Group Usa Rekombinant anticoccidie-vaccine
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
EP0831897B1 (fr) 1995-06-07 2001-03-28 Pfizer Inc. Vaccination in ovo contre la coccidiose
DE69635472T2 (de) * 1995-07-03 2006-04-13 Akzo Nobel N.V. Impfstoff gegen Geflügelkokzidose
AU2590997A (en) * 1996-03-29 1997-10-22 Life Technologies, Inc. Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures
US6632923B1 (en) * 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
KR100490669B1 (ko) * 2001-08-30 2005-05-19 (주)아비코아생명공학연구소 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 ｓｃＦｖ 재조합 항체
ES2351299T3 (es) 2001-08-30 2011-02-02 Embrex, Inc. Procedimientos mejorados para la producción de ooquistes.
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
DE10330235A1 (de) * 2003-07-04 2005-01-20 Bayer Healthcare Ag Neues Eimeria Gen und Protein sowie deren Verwendung
US7348401B2 (en) * 2003-09-10 2008-03-25 Innate Biotech, Inc. Peptides that inhibit complement activation
EP1742656B1 (fr) * 2004-03-12 2010-06-16 University Of Georgia Research Foundation, Inc. Nouvel extrait de peau de cacahuète utilisé comme adjuvant de vaccin
US7087425B2 (en) * 2004-03-31 2006-08-08 Embrex, Inc. Method of purifying oocysts using enzymatic digestion of fecal debris
US20110078828A1 (en) * 2004-09-10 2011-03-31 Guardian Biotechnologies Inc. Multi epitope vaccine for poultry
EP1666489B1 (fr) * 2004-12-01 2007-11-21 Zeon Corporation ADN codant pour une protéine antigénique de eimeria apical membrane antigène 1 et utilisations de ceux-ci
CN100398156C (zh) * 2005-11-23 2008-07-02 南京农业大学 用于预防鸡球虫病的免疫调节型dna疫苗
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
US11701683B2 (en) 2010-12-22 2023-07-18 The Procter & Gamble Company Methods for foil stamping parts having asymmetrical edges
WO2018115229A1 (fr) 2016-12-22 2018-06-28 Intervet International B.V. Vaccin anti-eimeria à efficacité améliorée
EP3976816A4 (fr) * 2019-05-28 2023-10-25 Case Western Reserve University Compositions et procédés de préservation de la méthylation de l'adn
EP4158016A4 (fr) 2020-05-27 2024-06-05 Case Western Reserve University Compositions et procédés de préservation de la méthylation de l'adn

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2814039C3 (de) 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
EP0135712A3 (fr) * 1983-08-19 1987-05-27 American Cyanamid Company Antigènes et anticorps monoclonaux réactifs contre les sporozoites d'Eiméria Spp.
US4650676A (en) 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
EP0135073A3 (fr) * 1983-08-19 1987-05-27 American Cyanamid Company Antigènes et anticorps monoclonaux réactifs contre les mérozoites d'Eimeria Spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
CA1340520C (fr) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Proteines antigeniques et vaccins qui en renferment; anticorps protecteurs diriges vers eux pour prevenir la coccidiose causee par eimera tenella et eimera necatrix
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
EP0190254A4 (fr) * 1984-07-05 1987-03-09 Genex Corp Gene clone et son procede de preparation et d'utilisation.
DE3650540T2 (de) * 1985-12-03 1997-02-27 Solvay Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
EP0241139A3 (fr) * 1986-03-13 1989-04-19 Merck & Co. Inc. Vaccin anti-idiotypique contre la coccidiose
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
DE3855665D1 (de) * 1987-03-06 1996-12-19 Amgen Boulder Inc Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
EP0315073A2 (fr) * 1987-11-02 1989-05-10 Matsushita Electric Industrial Co., Ltd. Composition pour l'obtention d'images
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
NZ227597A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
AU620366B2 (en) * 1988-02-12 1992-02-20 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same
DE3926461A1 (de) * 1989-07-15 1991-01-24 Suttner Gmbh & Co Kg Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet

Also Published As

Publication number Publication date
ATE120489T1 (de) 1995-04-15
AU635704B2 (en) 1993-04-01
FI101453B1 (fi) 1998-06-30
PT90727A (pt) 1989-12-29
NO892251D0 (no) 1989-06-02
NO892251L (no) 1989-12-04
MC2039A1 (fr) 1990-05-30
FI101453B (fi) 1998-06-30
CA1340538C (fr) 1999-05-11
EP0344808A1 (fr) 1989-12-06
YU47880B (sh) 1996-05-20
CN1186695A (zh) 1998-07-08
HUT52963A (en) 1990-09-28
IE67544B1 (en) 1996-04-17
HU212505B (en) 1996-07-29
KR910000183A (ko) 1991-01-29
KR0156545B1 (ko) 1998-11-16
IL90489A0 (en) 1990-01-18
CN1187368A (zh) 1998-07-15
US20030175311A1 (en) 2003-09-18
CN1040126C (zh) 1998-10-07
FI892714L (fi) 1989-12-04
YU113889A (en) 1991-10-31
EP0344808B1 (fr) 1995-03-29
IE891812L (en) 1989-12-03
PT90727B (pt) 1994-11-30
FI892714A0 (fi) 1989-06-02
CN1077438C (zh) 2002-01-09
NZ229377A (en) 1992-06-25
ZA893740B (en) 1990-02-28
CN1076204C (zh) 2001-12-19
JP3051130B2 (ja) 2000-06-12
DE68921923D1 (de) 1995-05-04
US5661015A (en) 1997-08-26
CN1038837A (zh) 1990-01-17
AU3601689A (en) 1989-12-07
NO303876B1 (no) 1998-09-14
ES2070866T3 (es) 1995-06-16
AR241942A1 (es) 1993-01-29
DE68921923T2 (de) 1995-08-10
DK272889D0 (da) 1989-06-02
JPH037594A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
DK272889A (da) Vaccine
KR900011476A (ko) 백신 제제
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
DE3752263D1 (de) Impfstoffe
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK582589D0 (da) Lysbadeapparat
DK540389A (da) Immunstimulerende praeparat
DK189788D0 (da) Vaccine
KR890700356A (ko) 신규의 백신
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
BR8906898A (pt) Jamela
DK375488D0 (da) Vaccine
DK606288D0 (da) Praeparat
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DK343689D0 (da) Herbicidt praeparat
FR2628599B1 (fr) Support-tuteur
DD277186A3 (de) Waelzlagerseparator
DK653388D0 (da) Vaccine
IT216207Z2 (it) Taglia tigella
BR8806404A (pt) Multiregua
BR6800002U (pt) Multigabarito
BR6800099U (pt) Baleiro

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment